Natures Sunshine | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 128.34 M

Revenue: As of FY2025 Q3, the actual value is USD 128.34 M, beating the estimate of USD 120.3 M.

EPS: As of FY2025 Q3, the actual value is USD 0.3, beating the estimate of USD 0.16.

EBIT: As of FY2025 Q3, the actual value is USD 9.001 M.

Segment Revenue

• Asia: Net sales for the three months ended September 30, 2025, were $64.7 million, an increase of 17.1% compared to the same period in 2024.
• Europe: Net sales for the three months ended September 30, 2025, were $22.1 million, an increase of 12.7% compared to the same period in 2024.
• North America: Net sales for the three months ended September 30, 2025, were $36.2 million, an increase of 7.7% compared to the same period in 2024.
• Latin America and Other: Net sales for the three months ended September 30, 2025, were $5.3 million, a decrease of 13.1% compared to the same period in 2024.

Operational Metrics

• Gross Profit: For the three months ended September 30, 2025, gross profit was $94.0 million, representing 73.3% of net sales, compared to $81.8 million or 71.3% of net sales for the same period in 2024.
• Operating Income: For the three months ended September 30, 2025, operating income was $9.0 million, an increase from $5.3 million for the same period in 2024.
• Net Income: For the three months ended September 30, 2025, net income was $5.5 million, compared to $4.6 million for the same period in 2024.

Cash Flow

• Operating Cash Flow: For the nine months ended September 30, 2025, operating activities provided cash of $25.4 million, compared to $13.1 million in the same period in 2024.
• Investing Activities: Used $4.1 million for the nine months ended September 30, 2025, compared to $8.8 million for the same period in 2024.
• Financing Activities: Used $15.2 million for the nine months ended September 30, 2025, compared to $9.3 million for the same period in 2024.

Unique Metrics

• Foreign Exchange Impact: The strengthening of local currencies versus the U.S. dollar resulted in an approximate 1.5% or $1.7 million increase in net sales during the quarter.

Future Outlook and Strategy

• Core Business Focus: The company plans to continue monitoring the social, political, regulatory, and economic environment in Ukraine and Russia due to ongoing geopolitical issues.
• Non-Core Business: The company entered into share purchase agreements to acquire Fosun Industrial’s interest in two joint ventures, Nature’s Sunshine Hong Kong Limited and Shanghai Nature’s Sunshine Health Products Co., Ltd., for cash consideration of $3.9 million and $3.1 million, respectively.